Lilly’s Prasugrel Superior To Bristol’s Plavix In Reducing CV Events In Pivotal TRITON Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Efficacy tempered by an increase in non-CABG bleeding compared to clopidogrel.